SCHEMBL5376294

SCHEMBL5376294

Cc1cc(Cl)ccc1Cn1nc(/C=C/CCCO)c2ccc(OC(F)(F)F)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.36
PPARG P37231 11/20 0.35
PPARA Q07869 8/20 0.35
CYP2C9 P11712 2/20 0.35
KCNH2 Q12809 2/20 0.35
EGFR P00533 1/20 0.35
CHRM4 P08173 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRA2A P08913 1/20 0.35
ALOX5 P09917 1/20 0.35
ADRB3 P13945 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA2B P18089 1/20 0.35
CHRM3 P20309 1/20 0.35
TACR2 P21452 1/20 0.35
DRD1 P21728 1/20 0.35
TBXA2R P21731 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376297 1.00 ENPP2 (0.36) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5342918 0.95 ENPP2 (0.37) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5342922 0.95 ENPP2 (0.37) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5359999 0.91 NPSR1 (0.38) ENPP2PPARGCYP2C9F2RL3CYP1A2
SCHEMBL5359991 0.91 NPSR1 (0.38) ENPP2PPARGCYP2C9F2RL3CYP1A2
SCHEMBL5317489 0.91 ENPP2 (0.38) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5317486 0.91 ENPP2 (0.38) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5337864 0.90 ENPP2 (0.38) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5337868 0.90 ENPP2 (0.38) ENPP2PPARGPPARACYP2C9KCNH2
SCHEMBL5318741 0.86 ENPP2 (0.39) ENPP2PPARGCYP2C9PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed